Liraglutide is a human GLP-1 analog with 97% amino acid homology to native human GLP-1 (6), and its protective actions against diabetes are mediated at the level of the β cell, as well as in peripheral tissues. This evidence concerns the gene GLP1R and diabetes mellitus.